| A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells S Sahoo, A Mishra, H Kaur, K Hari, S Muralidharan, S Mandal, MK Jolly NAR cancer 3 (3), zcab027, 2021 | 68 | 2021 |
| Immunosuppressive traits of the hybrid epithelial/mesenchymal phenotype S Sahoo, SP Nayak, K Hari, P Purkait, S Mandal, A Kishore, H Levine, ... Frontiers in immunology 12, 797261, 2021 | 60 | 2021 |
| Epithelial-to-mesenchymal transition enhances cancer cell sensitivity to cytotoxic effects of cold atmospheric plasmas in breast and bladder cancer systems P Wang, R Zhou, P Thomas, L Zhao, R Zhou, S Mandal, MK Jolly, ... Cancers 13 (12), 2889, 2021 | 43 | 2021 |
| Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial–hybrid–mesenchymal spectrum in cancer S Muralidharan, S Sahoo, A Saha, S Chandran, SS Majumdar, S Mandal, ... Biomolecules 12 (2), 297, 2022 | 22 | 2022 |
| Single-cell analysis reveals partial reactivation of X chromosome instead of chromosome-wide dampening in naive human pluripotent stem cells S Mandal, D Chandel, H Kaur, S Majumdar, M Arava, S Gayen Stem Cell Reports 14 (5), 745-754, 2020 | 20 | 2020 |
| PD-L1 activity is associated with partial EMT and metabolic reprogramming in carcinomas S Muralidharan, M Sehgal, R Soundharya, S Mandal, SS Majumdar, ... Current Oncology 29 (11), 8285-8301, 2022 | 18 | 2022 |
| Transcriptomic-based quantification of the epithelial-hybrid-mesenchymal spectrum across biological contexts S Mandal, T Tejaswi, R Janivara, S Srikrishnan, P Thakur, S Sahoo, ... Biomolecules 12 (1), 29, 2021 | 13 | 2021 |
| Semicoordinated allelic-bursting shape dynamic random monoallelic expression in pregastrulation embryos HC Naik, K Hari, D Chandel, S Mandal, MK Jolly, S Gayen IScience 24 (9), 2021 | 13 | 2021 |
| Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling F Bocci, S Mandal, T Tejaswi, MK Jolly Computational and Systems Oncology 1 (2), e1015, 2021 | 13 | 2021 |
| In silico analysis of ion channels and their correlation with epithelial to mesenchymal transition in breast cancer KTS Parthasarathi, S Mandal, S Singh, S Gundimeda, MK Jolly, A Pandey, ... Cancers 14 (6), 1444, 2022 | 12 | 2022 |
| Unique sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes A Kar, N Medatwal, K Rajput, S Mandal, T Pani, A Khan, P Sharma, ... International Journal of Cancer 152 (11), 2410-2423, 2023 | 6 | 2023 |
| Analysis of yes-associated protein-1 (YAP1) target gene signature to predict progressive breast cancer G Venkatasubramanian, DA Kelkar, S Mandal, MK Jolly, M Kulkarni Journal of Clinical Medicine 11 (7), 1947, 2022 | 6 | 2022 |
| An integrative systems biology approach identifies molecular signatures associated with gallbladder cancer pathogenesis N Roy, M Kshattry, S Mandal, MK Jolly, DK Bhattacharyya, P Barah Journal of Clinical Medicine 10 (16), 3520, 2021 | 5 | 2021 |
| Aberrations in ion channels interacting with lipid metabolism and epithelial mesenchymal transition in esophageal squamous cell carcinoma KT Parthasarathi, S Mandal, JP George, KB Gaikwad, S Sasidharan, ... Frontiers in Molecular Biosciences 10, 1201459, 2023 | 3 | 2023 |
| Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer S Sahoo, S Ramu, MG Nair, M Pillai, BP San Juan, HZ Milioli, S Mandal, ... Iscience 27 (7), 2024 | 2 | 2024 |
| An Endosomal Acid-Regulatory Feedback System Rewires Cytosolic cAMP Metabolism and Drives Tumor Progression H Prasad, S Mandal, JKK Mathew, A Cherukunnath, AS Duddu, ... Molecular Cancer Research 22 (5), 465-481, 2024 | 2 | 2024 |
| Transcriptional bursting shape autosomal dynamic random monoallelic expression in pre-gastrulation embryos CH Naik, D Chandel, S Mandal, S Gayen bioRxiv, 2020 | 2 | 2020 |
| Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer S Sahoo, S Ramu, MG Nair, M Pillai, BP San Juan, HZ Milioli, S Mandal, ... bioRxiv, 2023 | 1 | 2023 |
| Identification and characterization of Nattokinase producing bacteria and optimization of enzyme production D Choubey, K Dhusia, N Gupta, NA Viswan, S Mandal | 1 | 2016 |
| Comparative transcriptomic analysis uncovers molecular heterogeneity in hepatobiliary cancers N Roy, R Lodh, S Mandal, MK Jolly, A Sarma, DK Bhattacharyya, P Barah Translational Oncology 51, 102192, 2025 | | 2025 |